Use of IL-23 and IL-17 antagonists to treat autoimmune ocular inflammatory disease
摘要
<p>Drug products for use in treating autoimmune ocular inflammatory disease are disclosed, which involve administration of agents that antagonize one or both of IL-17 and IL-23 activity.</p>
申请公布号
EP2322219(A3)
申请公布日期
2013.06.05
申请号
EP20100180648
申请日期
2006.08.30
申请人
MERCK SHARP & DOHME CORP.;THE GOVERNMENT OF THE U.S.A. AS REPRESENTED BY THE SECRETARY OF THE DEPT. OF HEALTH & HUMAN SERVICES
发明人
CUA, DANIEL J.;KASTELEIN, ROBERT, A.;TSAI, VAN, T.;CASPI, RACHEL;SILVER, PHYLLIS;LUGER, DROR
